Feb 28, 2024, 07:34 AM by

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images

Feb 28, 2024, 07:34 AM by

New Kalderos board members bring broad legal, regulatory, and corporate leadership experience across healthcare, biopharmaceutical, and pharmacy industries.

Feb 28, 2024, 07:34 AM by

Optibrium has launched Semeta™, a metabolism prediction platform tailored specifically for drug metabolism and pharmacokinetics (DMPK) scientists. Fundamental to improving a drug’s chance of clinical success, Semeta allows the accurate prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery, with superior precision to comparable software.

Feb 28, 2024, 07:34 AM by

Also, in 2023, Avalon launched Precision Genetic Testing Management (PGTM), the next evolution of its genetic test management solution.

Feb 28, 2024, 07:34 AM by

Feb 28, 2024, 07:34 AM by

Discovery Park, Kent’s thriving life science community, is marking International Women’s Day by supporting women in business and tackling gender bias in healthcare.

Feb 28, 2024, 07:34 AM by

The healthcare industry is embracing automation and robotics, offering exciting changes. Automation empowers healthcare providers by streamlining tasks and allowing for personalized medicine.

Feb 28, 2024, 07:34 AM by

Feb 28, 2024, 07:34 AM by

Feb 28, 2024, 01:00 AM by User Not Found

Bio-IT World | Freenome will advance the pipeline of single-cancer and tailored multi-cancer early detection tests built on its multiomics platform; Capitainer plans to advance its journey toward becoming the foremost provider of self-sampling solutions with new funding, including scaling up production capacity, enhancing sales and marketing strategies, and launching new products; COUR will advance multiple, wholly owned product candidates that leverage the company’s immune tolerance platform, including Phase 2a proof-of-concept clinical studies in Myasthenia Gravis and Type 1 Diabetes, and other pipeline opportunities; and more.

Feb 27, 2024, 08:42 AM by

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.

Feb 27, 2024, 08:42 AM by

Feb 27, 2024, 08:42 AM by

Feb 27, 2024, 08:42 AM by

In recent years, the demand for dietary supplements has been on the rise as more and more individuals seek to maintain a healthy lifestyle. Alfa Chemistry, a renowned chemical supplier, has unveiled its selection of dietary supplements, offering consumers a wide range of options to support their nutritional needs. With its new product line, including Fruit Juice Powder, Enzyme Powder, and Probiotics Product, Alfa Chemistry aims to provide natural and effective solutions for various health concerns.

Feb 27, 2024, 08:42 AM by

PandaOmics is a cloud-based software platform from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine that helps researchers identify therapeutic targets and discover new biomarkers in order to select the most promising targets to pursue based on all available data and pre-existing research. A new paper in the Journal of Chemical Information and Modeling provides definitive validation of this software platform.

Feb 27, 2024, 08:42 AM by

Feb 27, 2024, 08:42 AM by

Driven by the rise of chronic wounds, particularly those linked to diabetes, the healthcare industry sees a surge in innovative smart bandages. These advanced dressings offer faster healing, infection control, and real-time monitoring compared to traditional methods.

Feb 27, 2024, 08:42 AM by

Feb 27, 2024, 01:00 AM by User Not Found

Bio-IT World | Among the sequencing news at AGBT earlier this month, Ultima Genomics announced the commercial launch of its UG 100 ultra-high throughput sequencing platform.

Feb 26, 2024, 07:53 AM by